Cargando…

Overexpression of Ulk2 inhibits proliferation and enhances chemosensitivity to cisplatin in non-small cell lung cancer

The aim of the present study was to examine the function of unc-51 like autophagy activating kinase 2 (Ulk2) in non-small cell lung cancer (NSCLC). Western blotting was used to analyze the protein expression of Ulk2 in seven pairs of cancerous and adjacent non-cancerous NSCLC specimens. Reverse tran...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Hong, Yang, Ze-Tian, Bai, Yu-Quan, Cai, Yan-Fei, Zhao, Jin-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313100/ https://www.ncbi.nlm.nih.gov/pubmed/30655741 http://dx.doi.org/10.3892/ol.2018.9604

Ejemplares similares

Metformin-induced chemosensitization to cisplatin depends on P53 status and is inhibited by Jarid1b overexpression in non-small cell lung cancer cells
por: Tortelli, Tharcisio Citrangulo, et al.
Publicado: (2021)

Astragali radix total flavonoid synergizes cisplatin to inhibit proliferation and enhances the chemosensitivity of laryngeal squamous cell carcinoma
por: Cui, Jiajia, et al.
Publicado: (2019)

Overexpression of close homolog of L1 enhances the chemosensitivity of lung cancer cells via inhibition of the Akt pathway
por: Cai, Xiangdao, et al.
Publicado: (2020)

Silencing of lncRNA XIST inhibits non-small cell lung cancer growth and promotes chemosensitivity to cisplatin
por: Xu, Xiaohui, et al.
Publicado: (2020)

MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer
por: Shen, Hua, et al.
Publicado: (2016)

sCLU regulates cisplatin chemosensitivity of lung cancer cells in vivo
por: Ma, Guoliang, et al.
Publicado: (2015)

MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4
por: Ning, Fang-ling, et al.
Publicado: (2014)

PEDF inhibits non-small cell lung cancer proliferation by suppressing autophagy through downregulation of AMPK-ULK1 signaling
por: Miao, Haoran, et al.
Publicado: (2022)

miR-194 inhibits the proliferation, invasion, migration, and enhances the chemosensitivity of non-small cell lung cancer cells by targeting forkhead box A1 protein
por: Zhu, Xuchao, et al.
Publicado: (2016)

Metuzumab enhanced chemosensitivity and apoptosis in non-small cell lung carcinoma
por: Feng, Fei, et al.
Publicado: (2017)

Inhibition of Kpnβ1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer
por: Chi, Ru-pin Alicia, et al.
Publicado: (2021)

CRTAC1 enhances the chemosensitivity of non-small cell lung cancer to cisplatin by eliciting RyR-mediated calcium release and inhibiting Akt1 expression
por: Jin, Zihui, et al.
Publicado: (2023)

DNA-PK inhibition by M3814 enhances chemosensitivity in non-small cell lung cancer
por: Wang, Manni, et al.
Publicado: (2021)

Metformin enhances the chemosensitivity of hepatocarcinoma cells to cisplatin through AMPK pathway
por: Dong, Hao, et al.
Publicado: (2017)

RNAi-mediated silencing of CD147 inhibits tumor cell proliferation, invasion and increases chemosensitivity to cisplatin in SGC7901 cells in vitro
por: Wang, Bo, et al.
Publicado: (2010)

The Chinese medicine JC-001 enhances the chemosensitivity of Lewis lung tumors to cisplatin by modulating the immune response
por: Chuang, Meng-Hsien, et al.
Publicado: (2017)

Overexpression of miR-100 inhibits cell proliferation, migration, and chemosensitivity in human glioblastoma through FGFR3
por: Luan, Yongxin, et al.
Publicado: (2015)

Silencing of tripartite motif (TRIM) 29 inhibits proliferation and invasion and increases chemosensitivity to cisplatin in human lung squamous cancer NCI-H520 cells
por: Liu, Chunxiao, et al.
Publicado: (2015)

Cell fate determination in cisplatin resistance and chemosensitization
por: Luong, Khanh V., et al.
Publicado: (2016)

Shuyu pills inhibit immune escape and enhance chemosensitization in hepatocellular carcinoma
por: Deng, Zhe, et al.
Publicado: (2021)

ATR-Chk1 signaling inhibition as a therapeutic strategy to enhance cisplatin chemosensitivity in urothelial bladder cancer
por: Li, Ching-Chia, et al.
Publicado: (2015)

Knockdown of PDIA6 Inhibits Cell Proliferation and Enhances the Chemosensitivity in Gastric Cancer Cells
por: Yan, Chao, et al.
Publicado: (2020)

The ingenious ULKs: expanding the repertoire of the ULK complex with phosphoproteomics
por: Mercer, Thomas J., et al.
Publicado: (2021)

TOPK inhibits autophagy by phosphorylating ULK1 and promotes glioma resistance to TMZ
por: Lu, Hui, et al.
Publicado: (2019)

p21WAF1/CIP1 gene transcriptional activation exerts cell growth inhibition and enhances chemosensitivity to cisplatin in lung carcinoma cell
por: Wei, Junxia, et al.
Publicado: (2010)

miR-218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin
por: Tian, Hang, et al.
Publicado: (2022)

VX680 suppresses the growth of HepG2 cells and enhances the chemosensitivity to cisplatin
por: YAO, RUCHENG, et al.
Publicado: (2014)

Naa10p Enhances Chemosensitivity to Cisplatin in Oral Squamous Cell Carcinoma Cells
por: Sun, Lichun, et al.
Publicado: (2021)

Chemosensitizing and nephroprotective effect of resveratrol in cisplatin –treated animals
por: Osman, Abdel-Moneim M, et al.
Publicado: (2015)

Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer
por: Gąsiorkiewicz, Bartosz Mateusz, et al.
Publicado: (2020)

The incredible ULKs
por: Alers, Sebastian, et al.
Publicado: (2012)

Demethylzeylasteral inhibits cell proliferation and enhances cell chemosensitivity to 5-fluorouracil in Colorectal Cancer cells
por: Yang, Yang, et al.
Publicado: (2020)

Targeting P21-activated kinase suppresses proliferation and enhances chemosensitivity in T-cell lymphoblastic lymphoma
por: Su, Ning, et al.
Publicado: (2023)

MKP1 mediates chemosensitizer effects of E1a in response to cisplatin in non-small cell lung carcinoma cells
por: Cimas, Francisco J., et al.
Publicado: (2015)

Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway
por: Wu, Li-Mei, et al.
Publicado: (2021)

HHIP overexpression inhibits the proliferation, migration and invasion of non-small cell lung cancer
por: Zhao, Jian-Guo, et al.
Publicado: (2019)

miR-146a Inhibits Proliferation and Enhances Chemosensitivity in Epithelial Ovarian Cancer via Reduction of SOD2
por: Cui, YaJie, et al.
Publicado: (2016)

Cordycepin augments the chemosensitivity of osteosarcoma to cisplatin by activating AMPK and suppressing the AKT signaling pathway
por: Li, Hong-Bo, et al.
Publicado: (2021)

Overexpression of IL-7 enhances cisplatin resistance in glioma
por: Cui, Lei, et al.
Publicado: (2012)

NRBP2 Overexpression Inhibits Cell Proliferation and Migration and Increases Cisplatin Sensitivity in Intrahepatic Cholangiocarcinoma
por: Li, Xiaopeng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_k31dkgcp3n96tgue7tjfov8ifg